Sun Pharma gains 3% on USFDA approval for psoriasis drug Ilumya
- Published
- Genre
- News & Current Affairs
External source
starindiamarketresearch.wordpress.com External website
You are viewing the Vahuk Story page. The link above opens the shared source website.
Ilumya is used for the treatment of the most common plaque psoriasis – a chronic immune disease that appears on the skin. Shares of Sun Pharmaceutical Industries gained 3.4 percent in the early trade on Thursday as it has received USFDA approval for its psoriasis drug Ilumya. To Get Free Trial Missed call @ 9582541010 Call Us @ 8822117117 …
Community reactions
Karma 22.5
0
reactions
Discussion
0 comments
No comments yet. Be the first to join the discussion.